[755] UTILITY OF A COMBINATION OF NON-INVASIVE BIOMARKERS (FIBROMAX) IN ASSESSING THE EFFICACY OF ROSIGLITAZONE IN A ONE YEAR RANDOMIZED, DOUBLE-BLIND TRIAL IN NON ALCOHOLIC STEATOHEPATITIS

Authors :: Mona Munteanu
Philippe Podevin
S. Jacqueminot
Thierry Poynard
Frédéric Charlotte
Lawrence Serfaty
Djamila Messous
V. Ratziu
A. Grimaldi
Eric Bruckert
Source :: Journal of Hepatology. 46:S283
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Non invasive biomarkers
Non alcoholic
medicine.disease
Gastroenterology
Double blind
Internal medicine
medicine
Steatohepatitis
business
Rosiglitazone
medicine.drug

Full Text Access

Tools